Eglaro-S 5mg/100mg for Type 2 Diabetes Control
Eglaro-S Tablets 5mg/100mg contain sitagliptin (DPP-4 inhibitor) and metformin, a dual-combination oral antidiabetic therapy for adults with type 2 diabetes. Sitagliptin increases insulin release and reduces glucagon in a glucose-dependent manner, while metformin lowers liver glucose production and improves insulin sensitivity. A prescription is required for this medication.
Pay in 3 Installments of
Rs.
258
Eglaro-s 5mg/100mg for Type 2 Diabetes Control
Description
Eglaro-S Tablets 5mg/100mg – Dual Action Blood Sugar Management Therapy
Eglaro-S Tablets 5mg/100mg are a prescription oral antidiabetic medication used to manage type 2 diabetes mellitus in adults. This dual-combination therapy contains sitagliptin and metformin, offering effective blood sugar control when lifestyle measures alone are not sufficient.
Sitagliptin belongs to the DPP-4 inhibitor class and works by increasing insulin release and decreasing glucagon levels in a glucose-dependent manner. Metformin reduces glucose production in the liver and improves insulin sensitivity. Together, these agents help regulate both fasting and post-meal blood sugar levels while minimizing the risk of excessive hypoglycemia.
Eglaro-S is suitable for patients who require combination therapy to achieve better glycemic control. When used consistently with a healthy diet and regular physical activity, it supports long-term diabetes management and helps reduce the risk of diabetes-related complications.
This medication should be used strictly under medical supervision, with regular monitoring of blood glucose levels to ensure safe and effective treatment.
How to Order Eglaro-S 5mg/100mg at Derma.pk
At Derma.pk, we ensure the authenticity of Eglaro-S Tablets 5mg/100mg, verified by licensed pharmacists. Delivery is available across Pakistan. For prescriptions or inquiries, contact sales@derma.pk or WhatsApp +92-320-5999650.
Usage & Benefits
Dual-mechanism blood sugar control targeting both insulin secretion and liver glucose output
Glucose-dependent insulin stimulation reduces risk of hypoglycaemia compared to sulphonylureas
Helps control fasting and post-meal blood sugar levels
Improves insulin sensitivity through the metformin component
Supports long-term glycaemic management when lifestyle measures alone are insufficient
Prescription combination tablet suitable for patients needing dual therapy
How To Use
Take Eglaro-S Tablets as prescribed by your doctor — dose and frequency are individualised.
Swallow the tablet whole with water; take with meals to reduce gastrointestinal side effects from metformin.
Maintain a balanced diet and regular physical activity during treatment.
Monitor blood glucose levels regularly as advised by your healthcare provider.
Do not stop or adjust the dose without medical guidance.
Important safety information: Sitagliptin has been associated with a risk of pancreatitis. Stop the medicine and seek immediate medical attention if you develop severe and persistent abdominal pain, sometimes radiating to the back. The metformin component can rarely cause lactic acidosis — contact your doctor if you experience unusual muscle pain, difficulty breathing, stomach discomfort, or feeling cold.
FAQs
What is Eglaro-S 5mg/100mg used for?
It is prescribed to improve blood sugar control in adults with type 2 diabetes mellitus as dual-combination therapy.
What are the active ingredients in Eglaro-S?
Eglaro-S contains sitagliptin (a DPP-4 inhibitor) and metformin (a biguanide). The Shopify title confirms 5mg sitagliptin and 100mg metformin per tablet.
Why should I take Eglaro-S with meals?
The metformin component can cause nausea, stomach upset, or diarrhoea when taken on an empty stomach. Taking it with food significantly reduces these side effects.
What are the signs of pancreatitis I should watch for?
Severe, persistent pain in the abdomen or back that does not go away. If you experience this, stop the medicine and seek emergency medical care immediately.
Is Eglaro-S suitable for type 1 diabetes?
No. This combination is not indicated for type 1 diabetes mellitus.



